GSK Results announcement for the first quarter 2011
GSK Q1 performance demonstrates continued progress with delivery of underlying sales growth, cash generation and pipeline visibility.
Reported sales -10%; underlying sales +4%
EPS before major restructuring 32.2p (+9%); dividend 16p (+7%)
Link zur vollständigen (englischen) Pressemeldung
Publiziert am: 27.04.2011
zurück